DRG provides onsite epidemiology support in BMS at the Princeton Pike location. We often tailor our syndicated epidemiological estimates to better support disease definition and populations of interested from BMS.

For expert assistance or custom research requests, contact DRG’s onsite epidemiologists at EpidemiologyBMS@teamdrg.com.

Current epidemiology deliverables are available as an Excel or PowerPoint files below and in the Downloads section at the top right of this page.

Table of contents

  • Rheumatoid Arthritis - Epidemiology - BMS Epidemiology Support
    • BMS Epidemiology Support
      • Customized Epidemiology Support for Bristol Myers Squibb
      • Rheumatoid Arthritis Epidemiology Dashboard
      • ACPA,SE, and RF Populations in Diagnosed RA

Author(s): Nicole Zhang, MPH

Nicole Zhang is an Epidemiologist at Decision Resources Group. She focuses on the epidemiology of oncology and cardiovascular disorders.

She holds an M.P.H. from Tufts Medical School where she specialized in epidemiology and biostatistics. She also holds a B.A. in Chemistry and Statistics from Mount Holyoke College. Prior to joining Decision Resources, she worked as a research analyst at Massachusetts General Hospital where she independently managed data from food information survey conducted in Chelsea, MA. She has also worked at Massachusetts Department of Public Health where she conducted secondary research in the fields of gestational diabetes.


Related Reports

Psoriasis - Landscape & Forecast - Disease Landscape & Forecast

The psoriasis therapy market has become increasingly lucrative owing to the growing use of targeted agents. The dominance of the tumor necrosis factor (TNF

View Details

Ulcerative Colitis - Landscape & Forecast - Disease Landscape & Forecast

The ulcerative colitis (UC) therapy market is expected to grow steadily over the next decade. The entry of first-in-UC

View Details

Prostate Cancer - Landscape & Forecast - Disease Landscape & Forecast

Prostate cancer is the most common cancer among men in developed countries. Hormonal agents are the mainstay of treatment for prostate cancer and are routinely used across lines. Zytiga (Johnson &a...

View Details

Multiple Sclerosis - Landscape & Forecast - Disease Landscape & Forecast

The maturing yet highly lucrative market for multiple sclerosis (MS) disease-modifying therapies (DMTs) will c...

View Details